Kailera Therapeutics, Inc. (KLRA) Volatility Skew

Implied volatility skew shows how IV varies across strike prices for a given expiration. Steeper skews indicate higher demand for downside protection relative to upside speculation.

Kailera Therapeutics, Inc. (KLRA) operates in the Healthcare sector, specifically the Biotechnology industry, with a market capitalization near $2.84B, listed on NASDAQ, employing roughly 145 people, carrying a beta of 0.00 to the broader market. Kailera Therapeutics is a clinical-stage biopharmaceutical company developing a diverse pipeline of next-generation therapies designed to treat obesity and related conditions. Led by Ronald C. Renaud Jr., public since 2026-04-17.

Volatility skew analysis compares implied volatility across strikes and expirations. No recent options activity for KLRA as of 2026-06-02; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.

Learn how volatility skew is reported and how to read the data →